| occur in patient | 0.57 |
| occur in clinical trials | 0.52 |
| complicate any of the f… | 0.38 |
| occur in approximately … | 0.31 |
| muscle weakness | 0.42 |
| cardiac arrest | 0.38 |
| paralysis | 0.35 |
| nausea | 0.33 |
| hospitalization | 0.25 |
| asymptomatic | 0.72 |
| fatal | 0.59 |
| severe | 0.57 |
| rare | 0.16 |
| manifested by increased… | 0.61 |
| treated | 0.57 |
| manifested by character… | 0.56 |
| characterized by irregu… | 0.30 |
| followed by ventricular… | 0.16 |